Filing Details
- Accession Number:
- 0001104659-22-097017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-01 16:06:42
- Reporting Period:
- 2022-08-30
- Accepted Time:
- 2022-09-01 16:06:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1811623 | Paxmedica Inc. | PXMD | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1809613 | Michael Derby | C/O Paxmedica, Inc. 303 South Broadway, Suite 125 Tarrytown NY 10591 | Executive Chairman | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-30 | 95,000 | $5.25 | 7,336,745 | No | 4 | P | Indirect | TardiMed Sciences, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | TardiMed Sciences, LLC |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 361,000 | Direct |
Footnotes
- Includes restricted stock units that vest as described in the Company's Registration Statement on Form S-1 (File No. 333-239676).
- These shares were purchased from the underwriters by TardiMed Sciences, LLC ("TardiMed") in the issuer's initial public offering, which closed on August 30, 2022. See footnote 3 for the reporting person's relationship to TardiMed.
- The reporting person is the Managing Partner of TardiMed and has sole voting and dispositive control over the shares of Common Stock held by the entity. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
